Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	16.42	-3.71	3.19
Graham Fair Price	inf	0.00	7.39
PEG	inf	0.00	0.26
Price/Book	inf	0.00	0.84
Price/Cash Flow	inf	0.00	12.17
Prices/Earnings	inf	0.00	5.46
Price/Sales	inf	0.00	5.02
Price/FCF	inf	0.00	12.17
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	0.00	1.00	1.00
Operating Margin	9.58	0.38	0.35
ROA	6.77	< 0.005	< 0.005
ROE	0.04	0.04	7.25
ROIC	0.02	0.02	-2.68
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	0.18	-0.04	375.43
Dividends QOQ	-1.00	0.00	inf
EBIT QOQ	0.15	0.09	-36.51
EPS QOQ	0.21	-1.00	380.00
FCF QOQ	1.63	-4.50	176.73
Revenue QOQ	0.23	< 0.005	-99.46
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	143.00	165.05	15.41
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.55	0.58	6.22
Quick Ratio	0.00	0.00	0.00
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	7.93	0.00	inf
Cash	25.61	0.00	inf
Capex	-0.07	0.00	inf
Free Cash Flow	0.55	0.00	inf
Revenue	1.33	0.00	inf
Naive Interpretation	member

05 - Per Share Metrics · Not Interpreted

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	0.00	0.00	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-9.67	-3.71	61.60
Naive Interpretation	Member

06 - Financial Health · Bad

Rating